See more : Global Power Synergy Public Company Limited (GPSC.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Shandong Xinhua Pharmaceutical Company Limited (0719.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shandong Xinhua Pharmaceutical Company Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Teradyne, Inc. (0LEF.L) Income Statement Analysis – Financial Results
- Damara Gold Corp. (DMR.V) Income Statement Analysis – Financial Results
- RHI Magnesita N.V. (RHIM.VI) Income Statement Analysis – Financial Results
- XR Immersive Tech Inc. (VRAR.CN) Income Statement Analysis – Financial Results
- Fortescue Metals Group Limited (FSUMF) Income Statement Analysis – Financial Results
Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
About Shandong Xinhua Pharmaceutical Company Limited
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.10B | 7.50B | 6.56B | 6.01B | 5.61B | 5.21B | 4.52B | 4.01B | 3.60B | 3.59B | 3.17B | 2.97B | 2.94B | 2.61B | 2.32B | 2.10B | 1.89B | 1.67B | 1.70B | 1.51B | 1.33B | 1.17B | 1.10B | 1.04B | 950.66M | 973.88M | 915.63M | 842.20M | 711.90M | 533.67M |
| Cost of Revenue | 5.78B | 5.47B | 4.79B | 4.19B | 3.73B | 3.65B | 3.25B | 3.01B | 2.76B | 2.85B | 2.66B | 2.45B | 2.39B | 2.13B | 1.88B | 1.80B | 1.60B | 1.37B | 1.39B | 1.27B | 1.03B | 858.63M | 766.75M | 735.00M | 677.22M | 724.99M | 709.22M | 635.85M | 586.75M | 391.78M |
| Gross Profit | 2.32B | 2.04B | 1.77B | 1.81B | 1.87B | 1.56B | 1.27B | 1.00B | 836.65M | 734.82M | 513.36M | 524.32M | 545.95M | 480.54M | 444.50M | 292.75M | 284.56M | 295.90M | 301.65M | 244.64M | 300.86M | 314.92M | 332.51M | 309.07M | 273.44M | 248.90M | 206.41M | 206.36M | 125.14M | 141.89M |
| Gross Profit Ratio | 28.66% | 27.15% | 27.04% | 30.22% | 33.44% | 29.92% | 28.08% | 24.94% | 23.26% | 20.47% | 16.20% | 17.64% | 18.59% | 18.38% | 19.14% | 13.96% | 15.08% | 17.75% | 17.78% | 16.19% | 22.65% | 26.83% | 30.25% | 29.60% | 28.76% | 25.56% | 22.54% | 24.50% | 17.58% | 26.59% |
| Research & Development | 419.24M | 345.66M | 341.37M | 298.35M | 235.40M | 186.98M | 161.17M | 110.31M | 82.04M | 51.57M | 40.09M | 30.11M | 34.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 506.90M | 156.55M | 104.76M | 105.31M | 104.70M | 85.81M | 77.80M | 85.99M | 94.31M | 93.28M | 85.39M | 96.18M | 72.22M | 165.14M | 159.58M | 117.40M | 129.00M | 135.45M | 115.37M | 125.10M | 118.94M | 110.62M | 108.55M | 98.78M | 87.58M | 103.63M | 57.55M | 54.46M | 45.13M | 48.64M |
| Selling & Marketing | 780.17M | 658.31M | 584.13M | 631.60M | 789.15M | 654.91M | 509.75M | 404.32M | 353.77M | 317.76M | 224.07M | 239.90M | 199.66M | 129.47M | 122.92M | 99.50M | 86.79M | 114.72M | 154.05M | 136.15M | 114.27M | 117.54M | 120.76M | 109.89M | 95.00M | 63.54M | 30.30M | 19.92M | 17.55M | 18.36M |
| SG&A | 1.30B | 814.86M | 688.89M | 736.91M | 893.86M | 740.72M | 587.55M | 490.31M | 448.08M | 411.05M | 309.47M | 336.08M | 271.89M | 294.61M | 282.50M | 216.90M | 215.79M | 250.17M | 269.42M | 261.25M | 233.21M | 228.16M | 229.31M | 208.67M | 182.58M | 167.17M | 87.85M | 74.38M | 62.69M | 67.01M |
| Other Expenses | 69.75M | 333.39M | 244.42M | 236.47M | 235.49M | -12.24M | -13.51M | 16.55M | 31.09M | 102.45M | 102.88M | 60.49M | 25.19M | 6.85M | 3.07M | 16.66M | 15.05M | 7.53M | 17.19M | 3.54M | 451.45K | -519.42K | 513.32K | -453.90K | -1.50M | -5.76M | 687.77K | 8.41M | 3.48M | 2.63M |
| Operating Expenses | 1.79B | 1.49B | 1.27B | 1.27B | 1.36B | 1.14B | 942.61M | 790.55M | 686.98M | 603.84M | 464.98M | 471.02M | 388.87M | 309.31M | 296.05M | 226.56M | 227.71M | 259.41M | 274.99M | 271.10M | 241.43M | 231.35M | 235.92M | 215.50M | 189.34M | 172.40M | 93.53M | 77.63M | 65.80M | 69.36M |
| Cost & Expenses | 7.57B | 6.96B | 6.06B | 5.46B | 5.10B | 4.79B | 4.19B | 3.80B | 3.45B | 3.46B | 3.12B | 2.92B | 2.78B | 2.44B | 2.17B | 2.03B | 1.83B | 1.63B | 1.67B | 1.54B | 1.27B | 1.09B | 1.00B | 950.50M | 866.57M | 897.39M | 802.74M | 713.47M | 652.56M | 461.14M |
| Interest Income | 9.38M | 10.46M | 8.78M | 5.97M | 3.60M | 3.65M | 2.90M | 4.66M | 4.15M | 3.31M | 3.04M | 3.00M | 2.43M | 4.78M | 1.95M | 3.62M | 2.31M | 4.68M | 5.01M | 5.21M | 5.95M | 12.32M | 14.67M | -0.49 | -0.65 | -0.56 | -0.91 | -0.03 | -0.52 | -0.92 |
| Interest Expense | 41.15M | 49.71M | 53.10M | 59.76M | 55.32M | 54.55M | 52.75M | 63.66M | 83.56M | 74.82M | 68.58M | 56.92M | 28.10M | 19.16M | 19.31M | 17.96M | 12.18M | 20.37M | 22.41M | 15.38M | 14.02M | 13.80M | 18.07M | 9.05M | 8.56M | 7.71M | 14.23M | 33.92M | 20.83M | 9.99M |
| Depreciation & Amortization | 516.94M | 484.81M | 434.33M | 381.39M | 344.63M | 302.33M | 283.46M | 255.85M | 228.08M | 200.81M | 185.82M | 159.03M | 134.36M | 126.06M | 122.35M | 117.43K | 105.13M | 102.79M | 97.99M | 89.65M | 80.21M | 73.54M | 57.36M | 65.42M | 61.22M | 6.42M | 14.10M | 29.49M | 19.37M | 8.26M |
| EBITDA | 1.09B | 1.01B | 840.20M | 856.79M | 781.34M | 667.23M | 604.39M | 479.48M | 382.62M | 323.99M | 243.42M | 250.93M | 255.67M | 270.34M | 261.03M | 99.11M | 58.80M | 152.52M | 132.86M | 53.79M | 144.60M | 168.72M | 172.68M | 158.99M | 145.32M | 76.50M | 112.89M | 128.73M | 59.34M | 72.53M |
| EBITDA Ratio | 13.46% | 13.99% | 14.29% | 14.97% | 15.35% | 14.08% | 12.72% | 12.53% | 11.96% | 12.39% | 10.29% | 9.26% | 10.77% | 11.86% | 11.81% | 4.73% | 8.90% | 9.15% | 7.83% | 3.56% | 10.88% | 14.38% | 15.71% | 15.23% | 15.29% | 7.85% | 12.33% | 15.29% | 8.34% | 13.59% |
| Operating Income | 534.58M | 476.71M | 425.59M | 422.49M | 387.44M | 337.31M | 281.68M | 147.17M | 92.07M | 54.56M | -43.86M | -18.71M | 71.93M | 131.70M | 135.91M | 36.39M | 35.45M | 28.13M | -2.11M | -51.72M | 52.02M | 85.86M | 101.64M | 87.10M | 76.97M | 70.08M | 98.79M | 99.24M | 39.97M | 64.27M |
| Operating Income Ratio | 6.60% | 6.35% | 6.49% | 7.03% | 6.91% | 6.48% | 6.24% | 3.67% | 2.56% | 1.52% | -1.38% | -0.63% | 2.45% | 5.04% | 5.85% | 1.74% | 1.88% | 1.69% | -0.12% | -3.42% | 3.92% | 7.32% | 9.25% | 8.34% | 8.10% | 7.20% | 10.79% | 11.78% | 5.61% | 12.04% |
| Total Other Income/Expenses | -1.90M | -4.93M | -4.36M | -10.85M | -6.04M | -12.25M | -13.51M | 7.55M | 25.66M | 36.93M | 94.39M | -874.30K | 21.28M | -6.57M | -16.54M | 9.65M | 11.06M | 1.02M | 14.57M | 476.51K | -1.65M | -4.48M | -4.39M | -2.43M | -2.93M | -7.06M | 582.45K | 4.29M | 3.31M | 1.57M |
| Income Before Tax | 532.69M | 471.77M | 421.23M | 411.64M | 381.39M | 325.08M | 268.17M | 159.97M | 117.73M | 91.49M | 50.52M | 34.98M | 93.21M | 125.13M | 119.37M | 46.04M | 46.51M | 29.31M | 12.46M | -51.25M | 50.37M | 81.38M | 97.26M | 84.67M | 74.04M | 63.02M | 99.37M | 103.54M | 43.28M | 65.85M |
| Income Before Tax Ratio | 6.58% | 6.29% | 6.42% | 6.85% | 6.80% | 6.24% | 5.94% | 3.98% | 3.27% | 2.55% | 1.59% | 1.18% | 3.17% | 4.79% | 5.14% | 2.20% | 2.46% | 1.76% | 0.73% | -3.39% | 3.79% | 6.93% | 8.85% | 8.11% | 7.79% | 6.47% | 10.85% | 12.29% | 6.08% | 12.34% |
| Income Tax Expense | 26.58M | 45.46M | 59.16M | 64.52M | 58.28M | 50.79M | 46.93M | 26.92M | 23.72M | 23.15M | 12.21M | 8.72M | 13.59M | 22.36M | 13.44M | 6.37M | 8.37M | 7.64M | 9.80M | 5.35M | 8.38M | 12.56M | 16.31M | 15.49M | 10.40M | 10.24M | 14.91M | 15.15M | 6.42M | 10.21M |
| Net Income | 496.51M | 411.06M | 348.55M | 324.86M | 299.97M | 250.83M | 209.59M | 122.27M | 83.06M | 50.73M | 36.75M | 23.66M | 76.02M | 97.26M | 102.24M | 33.97M | 32.72M | 22.71M | 5.42M | -55.61M | 42.08M | 68.76M | 80.90M | 69.12M | 63.61M | 52.78M | 84.47M | 88.39M | 36.85M | 55.63M |
| Net Income Ratio | 6.13% | 5.48% | 5.31% | 5.41% | 5.35% | 4.82% | 4.64% | 3.05% | 2.31% | 1.41% | 1.16% | 0.80% | 2.59% | 3.72% | 4.40% | 1.62% | 1.73% | 1.36% | 0.32% | -3.68% | 3.17% | 5.86% | 7.36% | 6.62% | 6.69% | 5.42% | 9.22% | 10.49% | 5.18% | 10.42% |
| EPS | 0.72 | 0.62 | 0.56 | 0.52 | 0.48 | 0.40 | 0.35 | 0.21 | 0.14 | 0.08 | 0.07 | 0.04 | 0.13 | 0.16 | 0.17 | 0.05 | 0.05 | 0.04 | 0.01 | -0.09 | 0.07 | 0.12 | 0.14 | 0.12 | 0.11 | 0.10 | 0.15 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.72 | 0.61 | 0.56 | 0.52 | 0.48 | 0.40 | 0.35 | 0.21 | 0.14 | 0.08 | 0.07 | 0.04 | 0.13 | 0.16 | 0.17 | 0.05 | 0.05 | 0.04 | 0.01 | -0.09 | 0.07 | 0.12 | 0.14 | 0.12 | 0.11 | 0.10 | 0.15 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 689.60M | 663.22M | 622.41M | 621.86M | 621.86M | 621.86M | 598.83M | 588.69M | 594.51M | 599.48M | 565.55M | 614.64M | 581.36M | 602.06M | 604.17M | 630.79M | 607.71M | 612.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 691.95M | 674.09M | 622.41M | 624.73M | 624.93M | 622.72M | 598.83M | 588.71M | 599.89M | 599.48M | 565.55M | 615.25M | 581.36M | 602.06M | 604.17M | 630.79M | 607.71M | 612.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports